QLI Qilian International Holding Group Limited: Utang jangka cendhak perusahaan

The current share price of Qilian International (QLI), plotted on the chart at 0.00, reflects the dynamics of a business utilizing automated workshops to reduce medication packaging costs. Qilian International (QLI) is currently in a stage of R&D stagnation, focusing solely on raw material quality control. The firm generates revenue from the production of antibiotics and traditional remedies, combining them with agrochemicals to protect profits from government regulation.

This indicator aggregates all liabilities with a maturity horizon of up to one year, measuring the company's ability to service current liquidity without compromising operational activities. For Qilian International (QLI), which is scaling the production of biologicals through partnerships with agricultural holdings, the dynamics of short-term debt reflect the financing efficiency of raw material supply chains and the implementation pace of joint pharmaceutical projects.